Xcout IntelArkgen Bioscions competitors & alternatives
The 12 closest competitors and alternatives to Arkgen Bioscions among drug discovery companies — ranked by similarity to what Arkgen Bioscions actually does, not by market-cap band.
Subscribe to see Arkgen Bioscions’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Arkgen Bioscions
Arkgen Bioscions is a South Korean immuno-oncology startup headquartered in Daejeon. The company recently raised a $6.67 million Series A funding round to advance its proprietary biotech research. It focuses on developing innovative biopharmaceutical treatments.
Arkgen Bioscions at a glance
Arkgen Bioscions is a drug discovery company headquartered in South Korea. Its most recent funding round, Series A, raised $6.7M in July 2026. Xcout tracks 1 named person at Arkgen Bioscions, including Seungwon Lee (CEO).
Arkgen Bioscions leadership
- Seungwon LeeCEO
Arkgen Bioscions funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $6.7M | 14 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Arkgen Bioscions competitors
Ranked by semantic similarity — how close each company is to Arkgen Bioscions by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biopharma
Arch Oncology is a clinical-stage immuno-oncology company headquartered in Brisbane, California, with an additional scientific research laboratory in St. Louis, Missouri. The company develops antibody-based cancer therapies.
Similar drug discovery company
Coultreon Biopharma is a clinical-stage biotechnology company headquartered in Leuven, Belgium, focused on developing next-generation precision medicines for immunology and autoimmune diseases. Backed by substantial venture funding, the company advances innovative therapies.
Similar drug discovery company
Momotaro-Gene Inc. is a drug discovery company established in 2007 and headquartered in Okayama, Japan. The company focuses on pharmaceutical research and the development of next-generation cancer therapeutics.
Similar drug discovery company
Ahammune Biosciences is an India-based drug-discovery biotechnology company focused on developing small-molecule therapies for immune-mediated and inflammatory diseases. It serves pharmaceutical and healthcare markets by advancing novel immunomodulatory drug candidates toward clinical development.
Similar drug discovery company
OncoMyx Therapeutics, Inc. is a biotechnology company headquartered in Phoenix, Arizona, that develops innovative oncolytic immunotherapies to target and destroy tumors.
Biopharmaceuticals
ARMO BioSciences is a late-stage immuno-oncology company that develops a pipeline of novel, proprietary product candidates designed to activate the immune system of cancer patients to recognize and eradicate tumors.
Biopharmaceuticals
1ST Biotherapeutics is a South Korean biopharmaceutical company focused on discovering and developing treatments for neurodegenerative and other central nervous system diseases. Its work is aimed at patients with disorders such as Alzheimer’s disease and related conditions.
Biopharmaceutical
ExoCoBio Co., Ltd. is a biotechnology research and regenerative medicine company founded in 2017 and headquartered in Seoul, South Korea. The company specializes in developing exosome-based therapeutics and cosmetic solutions.
Biopharmaceutical
Celltrion is a leading biopharmaceutical company headquartered in Incheon, Republic of Korea. The company is expanding its new DS production facilities at its Songdo headquarters.
Biopharmaceuticals
Glionova AB is a Sweden-based, development-stage biopharmaceutical company founded in 2014 that focuses on developing cancer prevention therapies and treatments for difficult-to-treat cancers. The company's pipeline includes small-molecule oncolytic drugs, featuring its lead candidate GLN-1001.
Biopharmaceutical
Createrna, Inc. is an innovative biopharmaceutical company dedicated to the discovery and development of treatments for immunology, respiratory, and cardiovascular diseases. The company focuses its research pipeline on addressing complex chronic conditions through targeted therapeutic approaches. Their portfolio highlights early-stage pharmaceutical developments in specialized medical fields.
Microphysiological Systems
Founded in 2020 and headquartered in San Diego, California, with additional offices in Seoul, South Korea, Qureator is a biomedical startup company. The company focuses on biotechnology research and development, having secured significant venture funding.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Arkgen Bioscions and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Arkgen Bioscionsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →